H.R. Beal & Sons - Close Out Letter 7/16/14
- H.R. Beal & Sons
Department of Health and Human Services
|Food and Drug Administration|
New England District Office
One Montvale Avenue, 4th floor
Stoneham, MA 02180
July 16, 2014
Mr. Russell S. Bernard, President
Westport Capital Partners, LLC
40 Danbury Rd.
Wilton, CT. 06897-4406
Dear Mr. Bernard:
The Food and Drug Administration has completed an evaluation of H.R. Beal & Sons corrective actions in response to our Warning Letter [CMS 247295, November 22, 2011]. Based on our evaluation, it appears that your firm has addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Director Compliance Branch
New England District
cc: Frederick (Rob) Robert Bauer, General Manager
Po Box 225
Southwest Harbor, ME 04679-0225